16 results
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
27 Apr 22
Regulation FD Disclosure
4:34pm
resistant epilepsy - Seizure freedom - Better tolerability - Less issues for women of childbearing potential - Specific efficacy in difficult syndromes … choices for women who may become pregnant Burden of daily of medication taking Shortcomings of available ASM present opportunities for differentiation
8-K
EX-99.1
PRAX
Praxis Precision Medicines Inc
10 Jan 22
Regulation FD Disclosure
4:52pm
& PCDH19 + Phase 2b trial in women with menopausal and mood symptoms PRAX-114 Phase 2 trial for ET, PRAX-944 Phase 2 trial for PD and PRAX-562 trials
S-3ASR
PRAX
Praxis Precision Medicines Inc
3 Nov 21
Automatic shelf registration
5:08pm
. We are developing PRAX-114 for the treatment of major depressive disorder, women with menopausal and mood symptoms, post-traumatic stress disorder … are developing PRAX-114 for the treatment of major depressive disorder, women with menopausal and mood symptoms, post-traumatic stress disorder and essential
8-K
EX-99.1
66bcac
3 Nov 21
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:04am
8-K
EX-99.2
gd153d
3 Nov 21
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2021 Financial Results
7:04am
8-K
EX-99.1
cn76f2ph3nxte 2qzs
16 Aug 21
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2021 Financial Results
8:04am
10-K
9j5k9 2swr8u
17 Mar 21
Annual report
8:33am
424B4
6t8yzjj6upjw5rmzxd
16 Oct 20
Prospectus supplement with pricing info
4:02pm
S-1/A
vwa9n
9 Oct 20
IPO registration (amended)
6:09am
S-1
6nb kysmr8sxj68q
25 Sep 20
IPO registration
5:19pm
DRS/A
h12 4h85av8ipqvmvplf
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
l0w3zm9 5wt2j9ul
22 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next